Old Web
English
Sign In
Acemap
>
authorDetail
>
Sang-Yoon Lee
Sang-Yoon Lee
Pfizer
Medicine
Performance status
Pathology
Proportional hazards model
Leukopenia
3
Papers
55
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients
2015
Japanese Journal of Clinical Oncology
Hideyuki Akaza
Seiji Naito
Naomi Ueno
Kouji Aoki
Hiroyuki Houzawa
Susan Pitman Lowenthal
Sang-Yoon Lee
Show All
Source
Cite
Save
Citations (32)
Safety and Efficacy of Dacomitinib in Korean Patients with KRAS Wild-Type Advanced Non–Small-Cell Lung Cancer Refractory to Chemotherapy and Erlotinib or Gefitinib: A Phase I/II Trial
2014
Journal of Thoracic Oncology
Keunchil Park
B.C. Cho
Dong-Wan Kim
Myung-Ju Ahn
Sang-Yoon Lee
Diana Gernhardt
Ian Taylor
Alicyn K. Campbell
H. Zhang
Nagdeep Giri
Stephen P. Letrent
Joseph O’Connell
Dae S. Heo
Show All
Source
Cite
Save
Citations (14)
Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: A multicenter, cross-sectional study
2012
Asia-pacific Journal of Clinical Oncology
Do-Youn Oh
Bruce Crawford
Sung-Bae Kim
Hyun Cheol Chung
Jeffrey Mcdonald
Sang-Yoon Lee
Su Kyoung Ko
Jungsil Ro
Show All
Source
Cite
Save
Citations (9)
1